In particular, the anti-angiogenic microRNA miR-320a, by targeting NRP-1, suppressed the in vitro migration, adhesion and tubule formation by vascular endothelial cells, and reduced in vivo tumor angiogenesis and colon cancer cell migration and invasion (86, 87). This evidence concerns the gene NRP1 and neoplasm.